Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
暂无分享,去创建一个
J. Cruz | R. R. Lima | Maria Karolina Martins Ferreira | E. Fontes-Júnior | Daiane Claydes Baia-da-Silva | Cristian dos Santos Pereira
[1] Hong Chen,et al. Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via α1- and α2-Adrenergic Receptors. , 2023, ACS chemical neuroscience.
[2] Michael A. Veronin,et al. Tricyclic Antidepressants in Nociceptive and Neuropathic Pain: A Review of Their Analgesic Properties in Combination With Opioids , 2023, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.
[3] P. Martins‐Júnior,et al. Global research trends on maternal exposure to methylmercury and offspring health outcomes , 2022, Frontiers in Pharmacology.
[4] R. Daniels,et al. Classics in Chemical Neuroscience: Amitriptyline. , 2021, ACS chemical neuroscience.
[5] Amitriptyline , 2019, Reactions Weekly.
[6] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.
[7] H. Strothers. Depression in the primary care setting. , 2019, Ethnicity & disease.
[8] J. Ioannidis,et al. Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. , 2018, Focus.
[9] V. Pereira,et al. A brief history of antidepressant drug development: from tricyclics to beyond ketamine , 2018, Acta Neuropsychiatrica.
[10] Péter Jacsó,et al. The scientometric portrait of Eugene Garfield through the free ResearcherID service from the Web of Science Core Collection of 67 million master records and 1.3 billion references , 2018, Scientometrics.
[11] H. Obata. Analgesic Mechanisms of Antidepressants for Neuropathic Pain , 2017, International journal of molecular sciences.
[12] K. Lawson. A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia , 2017, Biomedicines.
[13] Weishu Liu,et al. The changing role of non‐English papers in scholarly communication: Evidence from Web of Science's three journal citation indexes , 2017, Learn. Publ..
[14] P. Cuijpers,et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis , 2016, The Lancet.
[15] K Longley,et al. EULAR revised recommendations for the management of fibromyalgia , 2016, Annals of the rheumatic diseases.
[16] J J Swen,et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants , 2013, Clinical pharmacology and therapeutics.
[17] S. Leucht,et al. Amitriptyline versus placebo for major depressive disorder. , 2012, The Cochrane database of systematic reviews.
[18] S. Silberstein,et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.
[19] W. Poewe,et al. The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[20] E. Feldman,et al. Evidence-based guideline: Treatment of painful diabetic neuropathy , 2011, Neurology.
[21] A. Serretti,et al. Antidepressants and body weight: a comprehensive review and meta-analysis. , 2010, The Journal of clinical psychiatry.
[22] P. Wiffen,et al. Antidepressants for neuropathic pain: a Cochrane review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[23] Ed C. M. Noyons,et al. A unified approach to mapping and clustering of bibliometric networks , 2010, J. Informetrics.
[24] Ludo Waltman,et al. Software survey: VOSviewer, a computer program for bibliometric mapping , 2009, Scientometrics.
[25] A. May,et al. EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force , 2009, European journal of neurology.
[26] P. Moayyedi,et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.
[27] C. Loprinzi,et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. , 2008, European journal of cancer.
[28] B. Pollock,et al. Anticholinergic Activity of 107 Medications Commonly Used by Older Adults , 2008, Journal of the American Geriatrics Society.
[29] M. Weller,et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis , 2008, Nature Medicine.
[30] Matthew E Falagas,et al. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] K Longley,et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome , 2007, Annals of the rheumatic diseases.
[32] P. Gillman. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated , 2007, British journal of pharmacology.
[33] W. Kühn‐Velten,et al. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[34] E. Begg,et al. Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice , 2006, Pharmacological Reviews.
[35] Lei Wang,et al. Three options for citation tracking: Google Scholar, Scopus and Web of Science , 2006, Biomedical digital libraries.
[36] E. Leinonen,et al. A review of the pharmacological and clinical profile of mirtazapine. , 2006, CNS drug reviews.
[37] S. Pandya,et al. Practice parameter: Corticosteroid treatment of Duchenne dystrophy - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society , 2006 .
[38] A. May,et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force , 2006, European journal of neurology.
[39] R. Stafford,et al. Off-label prescribing among office-based physicians. , 2006, Archives of internal medicine.
[40] M. Moskowitz,et al. Suppression of cortical spreading depression in migraine prophylaxis , 2006, Annals of neurology.
[41] Roger B. Davis,et al. Sham device v inert pill: randomised controlled trial of two placebo treatments , 2006, BMJ : British Medical Journal.
[42] J. Mann,et al. The medical management of depression. , 2005, The New England journal of medicine.
[43] T. Nii,et al. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. , 2005, International journal of pharmaceutics.
[44] Pal Pacher,et al. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? , 2004, Current pharmaceutical design.
[45] H. Jick,et al. Antidepressants and the risk of suicidal behaviors. , 2004, JAMA.
[46] J Licinio,et al. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response , 2004, Molecular Psychiatry.
[47] J. Duby,et al. Diabetic neuropathy: an intensive review. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[48] Christine Frahnert,et al. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[49] S. Ashwal,et al. CME Practice parameter : Evaluation of children and adolescents with recurrent headaches Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society , 2002 .
[50] H. Karadag,et al. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats , 2002, Neuroscience Letters.
[51] Karthik Venkatakrishnan,et al. Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models , 2001, Journal of clinical pharmacology.
[52] A. Rice,et al. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study , 2001, PAIN.
[53] K. Holroyd,et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. , 2001, JAMA.
[54] V. Setola,et al. Discovery of a novel member of the histamine receptor family. , 2001, Molecular pharmacology.
[55] E. Richelson,et al. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. , 2000, Life sciences.
[56] M. Fava,et al. Weight gain and antidepressants. , 2000, The Journal of clinical psychiatry.
[57] L. Bendtsen. Central Sensitization in Tension-Type Headache—Possible Pathophysiological Mechanisms , 2000, Cephalalgia : an international journal of headache.
[58] I. Anderson,et al. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. , 2000, Journal of affective disorders.
[59] H. Vedder,et al. Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.
[60] P. Keck,et al. Antidepressant treatment of fibromyalgia. A meta-analysis and review. , 2000, Psychosomatics.
[61] S. Leckband,et al. Randomized Double-blind Study Comparing the Efficacy of Gabapentin With Amitriptyline on Diabetic Peripheral Neuropathy Pain , 1999 .
[62] A. Staiano,et al. Childhood functional gastrointestinal disorders , 1999, Gut.
[63] J. Teasdale,et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. , 1999, Archives of general psychiatry.
[64] C. Sánchez,et al. Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding , 1999, Cellular and Molecular Neurobiology.
[65] S. McCleary,et al. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat , 1999, Pain.
[66] W A Ray,et al. Antidepressants and the risk of falls among nursing home residents. , 1998, The New England journal of medicine.
[67] F. Guengerich,et al. Cooperativity in oxidations catalyzed by cytochrome P450 3A4. , 1997, Biochemistry.
[68] H. J. McQuay,et al. A systematic review of antidepressants in neuropathic pain , 1996, Pain.
[69] C. Schmid,et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. , 1996, Arthritis and rheumatism.
[70] S. Straus,et al. Postherpetic neuralgia--pathogenesis, treatment, and prevention. , 1996, The New England journal of medicine.
[71] L. Mynors-Wallis,et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care , 1995, BMJ.
[72] D. Sibley,et al. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.
[73] F. Holsboer,et al. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. , 1993, Endocrinology.
[74] W A Ray,et al. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. , 1992, American journal of epidemiology.
[75] R Dubner,et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.
[76] Patrick Onghena,et al. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies , 1992, Pain.
[77] Wayne Katon,et al. Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.
[78] T M Itil,et al. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. , 1990, The Journal of clinical psychiatry.
[79] J. Davidson,et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. , 1990, Archives of general psychiatry.
[80] G H Guyatt,et al. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. , 1990, Annals of internal medicine.
[81] G. Leijon,et al. Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine , 1989, Pain.
[82] R. Dubner,et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia , 1988, Neurology.
[83] P. Linkowski,et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. , 1987, The Journal of clinical endocrinology and metabolism.
[84] R. Dubner,et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood , 1987, Neurology.
[85] R. Dealy,et al. The Pharmacological Treatment of Delusional Depression: Part II , 1986, Journal of clinical psychopharmacology.
[86] D. Felson,et al. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. , 1986, Arthritis and rheumatism.
[87] P. Benfield,et al. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. , 1986, Drugs.
[88] D. Charney,et al. Lithium carbonate augmentation of antidepressant treatment , 1984 .
[89] C. Montigny,et al. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. , 1983, Archives of general psychiatry.
[90] F. Petty,et al. Specificity of the learned helplessness model of depression , 1982, Pharmacology Biochemistry and Behavior.
[91] H. Merskey,et al. Amitriptyline versus placebo in post-herpetic neuralgia , 1981, PAIN.
[92] J. Green,et al. Tricyclic antidepressant drugs block histamine H2 receptor in brain , 1977, Nature.
[93] S. Snyder,et al. Antidepressants and the muscarinic acetylcholine receptor. , 1977, Archives of general psychiatry.
[94] R. O. Friedel,et al. Prediction of tricyclic antidepressant response: a critical review. , 1976, Archives of general psychiatry.
[95] J. Maas. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.
[96] G. Cohen,et al. Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.
[97] A. Beck,et al. The efficacy of antidepressant drugs. A review of research (1958-1972). , 1974, Archives of general psychiatry.
[98] G. Klerman,et al. Treatment of depression by drugs and psychotherapy. , 1974, The American journal of psychiatry.
[99] R. Braithwaite,et al. Plasma concentration of amitriptyline and clinical response. , 1972, Lancet.
[100] K. Fuxe,et al. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. , 1971, Neuropharmacology.
[101] S. Ross,et al. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. , 1969, European journal of pharmacology.
[102] T. Hökfelt,et al. Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. , 1969, European journal of pharmacology.
[103] T. Hökfelt,et al. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.
[104] G. Roberts,et al. The release of nucleotides, 5‐hydroxytryptamine and enzymes from human blood platelets during aggregation , 1968, The Journal of physiology.
[105] C. Dolea,et al. World Health Organization , 1949, International Organization.
[106] Raminta Pranckute,et al. Web of Science (WoS) and Scopus: The Titans of Bibliographic Information in Today's Academic World , 2021, Publ..
[107] Takahiro A. Kato,et al. Melatonin, Neuroprotective Agents and Antidepressant Therapy , 2016 .
[108] Alec B. O’Connor. Neuropathic Pain , 2012, PharmacoEconomics.
[109] Adolfo Alonso-Arroyo,et al. Which Data Base Should we Use for our Literature Analysis? Web of Science versus SCOPUS , 2011 .
[110] Adolfo Alonso-Arroyo,et al. Which data base should we use for our literature analysis? Web of Science versus SCOPUS. , 2011, Archivos de bronconeumologia.
[111] S. Evers,et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force , 2009 .
[112] Y. Swica,et al. Proposal for the inclusion of misoprostol in the WHO model list of essential medicines , 2009 .
[113] Report of the Quality Standards Subcommittee of the , 2010 .
[114] Nancy D Berkman,et al. Anorexia nervosa treatment: a systematic review of randomized controlled trials. , 2007, The International journal of eating disorders.
[115] E. Montgomery. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. , 2007, Neurology.
[116] Andrea Cipriani,et al. Imputing missing standard deviations in meta-analyses can provide accurate results. , 2006, Journal of clinical epidemiology.
[117] W. Weiner,et al. Practice Parameter: Evaluation and in Treatment of Depression, Psychosis and Dementia Parkinson Disease (An Evidence-Based Review) , 2006 .
[118] Wei Duan,et al. Herb-drug interactions: a literature review. , 2005, Drugs.
[119] D. Thomas,et al. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor , 2004, Psychopharmacology.
[120] M. Meaney,et al. The effects of chronic antidepressant treatment in an animal model of anxiety , 2004, Psychopharmacology.
[121] B. Thierry,et al. The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.
[122] P. O'Malley,et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. , 2000, The American journal of medicine.
[123] J. Pancrazio,et al. Inhibition of neuronal Na+ channels by antidepressant drugs. , 1998, The Journal of pharmacology and experimental therapeutics.
[124] J. Kelly,et al. The olfactory bulbectomized rat as a model of depression: an update. , 1997, Pharmacology & therapeutics.
[125] E. Paykel,et al. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. , 1988, Journal of affective disorders.
[126] S. Pond,et al. First-Pass Elimination Basic Concepts and Clinical Consequences , 1984, Clinical pharmacokinetics.
[127] F. Goodwin,et al. Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. , 1975, Archives of general psychiatry.
[128] S. Snyder,et al. Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. , 1971, Molecular pharmacology.